UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Blood, 2012-08, Vol.120 (7), p.1449-1457

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.726-734

2011

Link zum Volltext

Verfügbarkeit prüfen

OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.124-124

2013

Link zum Volltext

Verfügbarkeit prüfen

Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors

Proceedings of the National Academy of Sciences - PNAS, 1999-05, Vol.96 (10), p.5686-5691

1999

Link zum Volltext

Verfügbarkeit prüfen

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Journal of medicinal chemistry, 1998-03, Vol.41 (7), p.1060-1067

1998

Link zum Volltext

Verfügbarkeit prüfen

Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (13), p.1843-1846

1999

Link zum Volltext

Verfügbarkeit prüfen

Secreted Site-1 Protease Cleaves Peptides Corresponding to Luminal Loop of Sterol Regulatory Element-binding Proteins

The Journal of biological chemistry, 1999-08, Vol.274 (32), p.22805-22812

1999

Link zum Volltext

Verfügbarkeit prüfen

Hydrophilic, Pro-Drug Analogues of T138067 Are Efficacious in Controlling Tumor Growth In Vivo and Show a Decreased Ability To Cross the Blood Brain Barrier

Journal of medicinal chemistry, 2001-10, Vol.44 (22), p.3599-3605

2001

Link zum Volltext

Verfügbarkeit prüfen

Novel antineoplastic agents with efficacy against multidrug resistant tumor cells

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (19), p.2653-2656

1998

Link zum Volltext

Verfügbarkeit prüfen

Advances in the Discovery of C5a Receptor Antagonists

Annual Reports in Medicinal Chemistry, 2011, Vol.46, p.171-186

2011

Link zum Volltext

Verfügbarkeit prüfen

4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties

Journal of medicinal chemistry, 1990-01, Vol.33 (1), p.311-317

1990

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of m4 selective muscarinic antagonists

Bioorganic & medicinal chemistry letters, 1998-08, Vol.8 (15), p.1991-1996

1998

Link zum Volltext

Verfügbarkeit prüfen

Acetylcholinesterase inhibition by fused dihydroquinazoline compounds

Bioorganic & medicinal chemistry letters, 1996-03, Vol.6 (6), p.737-742

1996

Link zum Volltext

Verfügbarkeit prüfen

Aryl 1-But-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as Potential Antipsychotic Agents: Synthesis and Structure−Activity Relationships

Journal of medicinal chemistry, 1996-08, Vol.39 (16), p.3179-3187

1996

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

Bioorganic & medicinal chemistry letters, 1996-03, Vol.6 (6), p.679-682

1996

Link zum Volltext

Verfügbarkeit prüfen

Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF Receptor

Journal of medicinal chemistry, 1995-10, Vol.38 (22), p.4439-4445

1995

Link zum Volltext

Verfügbarkeit prüfen

Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists

Journal of medicinal chemistry, 1999-02, Vol.42 (3), p.356-363

1999

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors

Journal of medicinal chemistry, 1993-11, Vol.36 (24), p.3929-3936

1993

Link zum Volltext

Verfügbarkeit prüfen

2-(1,3,5-Dithiazinan-5-yl)ethanol Heterocycles, Structure and Reactivity

Heterocycles, 2004-10, Vol.63 (10), p.2269

2004

Link zum Volltext

Verfügbarkeit prüfen

Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.3014-3018

1996

Link zum Volltext

Verfügbarkeit prüfen

The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents

Journal of medicinal chemistry, 1994-10, Vol.37 (21), p.3523-3533

1994

Link zum Volltext

Verfügbarkeit prüfen

Characterization of muscarinic agonists in recombinant cell lines

Life sciences (1973), 1993, Vol.52 (5), p.465-472

1993

Link zum Volltext

Verfügbarkeit prüfen

Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones

Journal of medicinal chemistry, 1991-01, Vol.34 (1), p.248-256

1991

Link zum Volltext

Verfügbarkeit prüfen

Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine

Journal of medicinal chemistry, 1991-09, Vol.34 (9), p.2736-2746

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(38)
Pharmacology & Pharmacy
(29)
Chemistry, Medicinal
(24)
Animals
(19)
Chemistry
(19)
Biological And Medical Sciences
(18)
Humans
(17)
Medical Sciences
(17)
Pharmacology. Drug Treatments
(15)
Physical Sciences
(15)
Chemistry, Organic
(13)
Male
(12)
Rats
(12)
Mice
(9)
Neuropharmacology
(9)
Molecular Structure
(7)
Neurotransmitters. Neurotransmission. Receptors
(7)
Structure-Activity Relationship
(7)
Cricetinae
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose

OP0204 Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders

Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells

Secreted Site-1 Protease Cleaves Peptides Corresponding to Luminal Loop of Sterol Regulatory Element-binding Proteins

Hydrophilic, Pro-Drug Analogues of T138067 Are Efficacious in Controlling Tumor Growth In Vivo and Show a Decreased Ability To Cross the Blood Brain Barrier

Novel antineoplastic agents with efficacy against multidrug resistant tumor cells

Advances in the Discovery of C5a Receptor Antagonists

4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties

Identification and characterization of m4 selective muscarinic antagonists

Design and Synthesis of m1-Selective Muscarinic Agonists: (R)-(−)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI-1017), a Functionally m1-Selective Muscarinic Agonist

Acetylcholinesterase inhibition by fused dihydroquinazoline compounds

Aryl 1-But-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as Potential Antipsychotic Agents: Synthesis and Structure−Activity Relationships

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

Kynurenic Acid Derivatives Inhibit the Binding of Nerve Growth Factor (NGF) to the Low-Affinity p75 NGF Receptor

Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists

Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors

2-(1,3,5-Dithiazinan-5-yl)ethanol Heterocycles, Structure and Reactivity

Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology

The Discovery and Structure-Activity Relationships of 1,2,3,6-Tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine Autoreceptor Agonists and Potential Antipsychotic Agents

Characterization of muscarinic agonists in recombinant cell lines

Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones

Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine

Suchergebnisse filtern